Search Within

Craig Moskowitz

Formats
  1. Meeting Abstract (229)
  2. Journal Article (174)
  3. Book Section (3)
  4. Research Letter (1)
Groups
  1. Department of Medicine (407)
  2. Hematologic Malignancies, Division of (407)
  3. Center for Hematologic Malignancies (288)
  4. Lymphoma (273)
  5. Survivorship Research (176)
  6. Epidemiology and Biostatistics (103)

More Groups

People
  1. Andrew Zelenetz (207)
  2. David Straus (117)
  3. Paul Hamlin (113)
  4. Carol Portlock (106)
  5. Ariela Noy (94)
  6. Matthew Matasar (91)

More People

Years
  1. 2024 (1)
  2. 2023 (2)
  3. 2022 (3)
  4. 2021 (4)
  5. 2020 (6)
  6. 2019 (8)

More Years

Publications
  1. Blood (160)
  2. Journal of Clinical Oncology (46)
  3. Biology of Blood and Marrow Transplantation (23)
  4. Annals of Oncology (17)
  5. British Journal of Haematology (17)
  6. Haematologica (16)

More Publications

Publishers
  1. American Society of Hematology (165)
  2. American Society of Clinical Oncology (46)
  3. Elsevier Inc. (44)
  4. Oxford University Press (20)
  5. John Wiley & Sons (18)
  6. Ferrata Storti Foundation (16)

More Publishers

Results (407)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pembrolizumab in relapsed/refractory classical Hodgkin lymphoma: Primary end point analysis of the phase 2 keynote-087 study
    Meeting Abstract

    Moskowitz, C. H.; Zinzani, P. L.; Fanale, M. A.; Armand, P.; Johnson, N. A.; Radford, J. A.; Ribrag, V.; Molin, D.; Vassilakopoulos, T. P.; Tomita, A.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Preliminary results from a phase 1/2 study of brentuximab vedotin in combination with nivolumab in patients with relapsed or refractory Hodgkin lymphoma
    Meeting Abstract

    Herrera, A. F.; Bartlett, N. L.; Ramchandren, R.; Vose, J. M.; Moskowitz, A. J.; Feldman, T. A.; LaCasce, A. S.; Ansell, S. M.; Moskowitz, C. H.; Fenton, K.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Metabolic tumor volume to predict event free survival in patients with relapsed/refractory HL treated with brentuximab vedotin-based salvage therapy
    Meeting Abstract

    Gavane, S. C.; Ito, K.; Moskowitz, C. H.; Moskowitz, A. J.; Schoder, H.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • A randomized, phase 2 trial of denintuzumab mafodotin and RICE vs RICE alone in the treatment of patients (pts) with relapsed/refractory (r/r) diffuse large B-cell lymphoma (DLBCL) who are candidates for autologous stem cell transplant (ASCT)
    Meeting Abstract

    Chen, R. W.; Jacobsen, E. D.; Kostic, A.; Liu, T.; Moskowitz, C. H.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Pembrolizumab for relapsed/refractory classical Hodgkin lymphoma (R/R cHL): Phase 2 KEYNOTE-087 study
    Meeting Abstract

    Chen, R. W.; Zinzani, P. L.; Fanale, M. A.; Armand, P.; Johnson, N.; Ribrag, V.; Radford, J. A.; Tomita, A.; Shipp, M. A.; Wang, Y.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • KEYNOTE-013: An open-label, multicohort phase Ib trial of pembrolizumab in patients with advanced hematologic malignancies
    Meeting Abstract

    Kline, J.; Armand, P.; Kuruvilla, J.; Moskowitz, C.; Hamadani, M.; Ribrag, V.; Zinzani, P. L.; Chlosta, S.; Thompson, S.; Balakumaran, A.; more...
    Journal for ImmunoTherapy of Cancer (2016)

    Fulltext@MSK | Save
  • Phase 1b study of embrolizumab in patients with relapsed/refractory primary mediastinal large B-cell lymphoma: Results from the ongoing KEYNOTE-013 trial
    Meeting Abstract

    Zinzani, P. L.; Ribrag, V.; Moskowitz, C. H.; Michot, J. M.; Kuruvilla, J.; Balakumaran, A.; Zhang, Y.; Marinello, P.; Chlosta, S.; Gustafson, E.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • The use of a novel CME format to ellicit and develop true competence in hematologist ability to risk stratify patients with Hodgkin lymphoma
    Meeting Abstract

    Moskowitz, C. H.; Repetto, P.
    Blood (2016)

    Fulltext@MSK | Save
  • Outcome of initial observation in mantle cell lymphoma
    Meeting Abstract

    Kumar, A.; Ying, Z.; Alperovich, A.; Dogan, A.; Hamlin, P. A. Jr; Moskowitz, C. H.; Portlock, C. S.; Zelenetz, A. D.; Zhang, Z.; Woo, K. M.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Outcomes of follicular lymphoma patients by dynamic FLIPI at diagnosis and initial treatment in the post-rituximab era
    Meeting Abstract

    Batlevi, C.; Alperovich, A.; Smith, K.; Ying, Z.; Soumerai, J. D.; Copeland, A. R.; Joffe, E.; Caron, P.; Drullinsky, P.; Gerecitano, J. F.; more...
    Blood (2016)

    Fulltext@MSK | Save